Patent · US Active

Methods for the treatment of Prader-Willi-like syndrome or non-organic failure to thrive (NOFITT) feeding disorder using an agonist of the oxytocin receptor

US9125862B2 · kind B2 · utility

6Cited by

0References

8Claims

0Family size

Assignees

Institut National de la Sante et de la Recherche Medicale (INSERM) · FR
UNIVERSITE DE LA MEDITERRANEE · FR
CHU de Toulouse · FR

Inventors

Francoise Muscatelli · Nevers, FR
Maithe Tauber · Toulouse, FR
Fabienne Schaller · Marseilles, FR
Denise Thuilleaux · Hendaye, FR

Key dates

Filing date	Aug 29, 2014
Grant date	Sep 8, 2015
Priority date	—
Expiry date	Aug 29, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a compound which is an agonist of the oxytocin receptor o for use in the treatment of a feeding disorder with early-onset. In a particular embodiment, the agonist of the oxytocin receptor is the oxytocin or an active fragment thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.